Suraxavir trial finds faster flu recovery times for male but not female users
A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male ...
Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom duration
A systematic review and meta-analysis led by Shandong University in China has evaluated the comparative efficacy and safety of antiviral medications for treating nonsevere influenza. Findings indicate ...
Investornewsbreaks Nanoviricides (NYSE American: NNVC) To Present Broad-Spectrum Antiviral Innovations At Biotech Showcase 2025
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage company developing antiviral drugs designed to resist <a target=_blank href=https:// ...
Sportskeeda8d
"I couldn't walk for three months" - Mel Gibson's astounding revelation on Joe Rogan about controversial drug used for COVID-19 shakes up internet
American actor and filmmaker Mel Gibson unleashed a series of startling revelations during his appearance on The Joe Rogan Experience.
Mel Gibson Reveals Health Struggles and Controversial COVID-19 Treatment Experience
Actor Mel Gibson recently opened up about a challenging chapter in his life, sharing details of his battle with COVID-19 and ...
Mel Gibson claims Covid drug paralyzed him and killed his friend in shocking admission to Joe Rogan
The 69-year-old actor opened up about his harrowing experience which took place during the pandemic on Joe Rogan's podcast.
Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Highlights NV-387 As A Broad-Spectrum Antiviral Solution To Emerging Threats
NanoViricides, Inc. (NYSE American: NNVC) announced significant progress on NV-387, a broad-spectrum antiviral demonstrating superior efficacy in an ...
NanoViricides: Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are go ...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.
Frontiers27d
New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs
The choice of drug compounds reflects their accessibility, use in current experimental therapies, and demonstrated antiviral potential ... Pyronaridine, Remdesivir, Galidesvir, Chloroquine, Clomiphene ...